Morgan Stanley raises Synopsys target to USD 574: Synopsys stock falls 2.71 percent

Published on 10/23/2026 at 10:34 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Morgan Stanley lifted its target to USD 574.00 on October 20, 2026. Synopsys stock costs EUR 377.50, 2.71 percent below the Xetra close.

Targets and quarterly scale

Morgan Stanley lifted its Synopsys target from USD 500.00 to USD 574.00 on October 20, 2026.
Fiscal third-quarter revenue reached USD 2.48 billion, up 42.40 percent year over year.
Synopsys stock trades at EUR 377.50 at 10:30 a.m. CEST at Lang & Schwarz on October 23, 2026, 2.71 percent below the Xetra close of October 22, 2026.

Bauhaus-Poster mit geometrischen Formen, Schriftzug TECH und Chip-Motiv — Bauhaus-Poster kombiniert geometrische Formen mit Schriftzug TECH als Sinnbild für Synopsys Inc. (ISIN US8716071076) Chipdesign, Illustration mit AI erstellt.

Synopsys stock (ISIN US8716071076) was trading at EUR 377.50 at Lang & Schwarz on October 23, 2026, at 10:30 a.m. CEST, down 2.71 percent versus the Xetra close of October 22, 2026 at EUR 388.00. The latest catalyst was Morgan Stanley's target increase from USD 500.00 to USD 574.00 on October 20, 2026, while the bank maintained its Overweight rating, as MarketBeat reported.

Why the target moved higher

Morgan Stanley's October 20, 2026 note linked its view to artificial intelligence demand and Synopsys' shift toward consumption-based software pricing. The target rose USD 74.00, or 14.80 percent, from USD 500.00, but the market reaction remained negative in the euro quotation on October 23.

Three milestones and targets

Synopsys reported USD 2.477 billion of revenue for the fiscal third quarter on August 26, 2026. On October 5, 2026, the company entered a USD 1 billion accelerated share repurchase agreement with JPMorgan Chase, initially receiving approximately 1,735,000 shares, according to Synopsys. Morgan Stanley then raised its target to USD 574.00 from USD 500.00 on October 20, 2026, as MarketBeat reported.

The latest quarter gives the target debate measurable scale. Revenue of USD 2.477 billion was 42.40 percent higher than a year earlier, while GAAP earnings per diluted share reached USD 2.84, according to the company's fiscal-third-quarter release dated August 26, 2026. MarketBeat reported adjusted earnings per share of USD 3.91 against a USD 3.67 consensus estimate for the same quarter.

What comes next

Zacks lists December 9, 2026 as the estimated date for the next quarterly report, covering the period ending October 2026. The accelerated repurchase agreement is scheduled for final settlement by January 5, 2027, according to the October 5 company release.

Stock below the Xetra close

For investors, the contrast is direct: Morgan Stanley's USD 574.00 target rests on artificial intelligence expansion and execution, while the euro quotation stood EUR 10.50 below the prior Xetra close on October 23, 2026.

Synopsys stock was trading at EUR 377.50 at Lang & Schwarz on October 23, 2026, at 10:30 a.m. CEST, 2.71 percent below the Xetra close of October 22, 2026 at EUR 388.00. The further course of trading is shown by the continuously updated real-time quote of Synopsys stock.